Heparin update New Zealand

July 23, 2008

Email this news item to a friend/colleague Email this news item to a friend/colleague

Stewart Jessamine, Group Manager, Medsafe in conjunction with the Ministry of Health (NZ)  are continuing to monitor the situation with respect to the global problem of heparin contaminated with over-sulphated chondroitin sulphate (OSCS) entering the market.

Medicines regulators around the world have taken a number of different approaches to managing this issue.  In New Zealand, Medsafe requires all manufacturers of heparin-based products to test for the presence of OSCS in products supplied to the market. To date all of the manufacturers of heparin and low molecular weight heparin products supplied to New Zealand have reported that OSCS has not been detected in the products used by patients.

Click here for the full update.

Other stories

Written by IVTEAM · Filed Under All, IV News, IV Safety 

Add IVTEAM to Technorati Favorites del.icio.us:Heparin update New Zealand digg:Heparin update New Zealand spurl:Heparin update New Zealand wists:Heparin update New Zealand simpy:Heparin update New Zealand newsvine:Heparin update New Zealand blinklist:Heparin update New Zealand furl:Heparin update New Zealand reddit:Heparin update New Zealand fark:Heparin update New Zealand blogmarks:Heparin update New Zealand Y!:Heparin update New Zealand smarking:Heparin update New Zealand magnolia:Heparin update New Zealand segnalo:Heparin update New Zealand gifttagging:Heparin update New Zealand

Comments

Please leave a comment?